Bluejay Diagnostics, Inc. (BJDX) vs Catheter Precision, Inc. (VTAK)

Bluejay Diagnostics, Inc. and Catheter Precision, Inc. are both Medical Devices companies. Bluejay Diagnostics, Inc. is the larger, with a market value of $4.3M against $3.0M — 1.4× the size. Catheter Precision, Inc. has negative trailing earnings, so its P/E is not meaningful; Bluejay Diagnostics, Inc. trades at 1.2×. Bluejay Diagnostics, Inc. has the higher net margin (0.00% vs −711.5%) and the higher return on invested capital (0.00% vs −64.4%). Across the 14 metrics below, Bluejay Diagnostics, Inc. leads on 10 and Catheter Precision, Inc. on 4.

Valuation

Metric BJDX VTAK Medical Devices median
P/E 1.15 n/m 22.18
P/S n/m 0.22 2.70
P/B 0.20 0.02 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA 1.01 n/m 11.78
EV/Sales n/m 1.00 2.38
Earnings yield 86.67% (4,593.33%) (8.22%)
Free cash flow yield (326.05%) (2,257.96%) (7.80%)

Profitability

Metric BJDX VTAK Medical Devices median
Gross margin 0.00% 47.73% 56.01%
Operating margin 0.00% (1,000.26%) (15.03%)
Net margin 0.00% (711.49%) (20.40%)
Free cash flow margin 0.00% (489.45%) (7.24%)
Return on equity (98.89%) (115.04%) (15.32%)
Return on assets (81.07%) (43.65%) (19.72%)
Return on invested capital 0.00% (64.41%) (10.33%)

Growth

Metric BJDX VTAK Medical Devices median
Revenue growth (TTM) — 219.17% 8.80%
EPS growth (last fiscal year) 96.66% 87.48% —
Revenue growth, 5-year CAGR — 25.89% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BJDX VTAK Medical Devices median
Debt to equity 0.00 0.19 0.07
Current ratio 4.64 0.19 2.50
Net debt to EBITDA 0.76 (0.16) 0.49

Dividend

Metric BJDX VTAK Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric BJDX VTAK Medical Devices median
Market cap 4.28m 2.99m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack